Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  439 results for ""Proteasome Inhibitor""

Your Filters

Collection : Wiley Online Library (Open Access Articles Via Crossref)
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma

  • Source: Cancer Medicine ; volume 13, issue 14 ; ISSN 2045-7634 2045-7634

Record details

Read More Add to Saved list
×
Academic Journal

Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells

  • Source: The Kaohsiung Journal of Medical Sciences ; volume 40, issue 6, page 542-552 ; ISSN 1607-551X 2410-8650

Record details

Read More Add to Saved list
×
Academic Journal

Interleukin‐33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species‐mediated inhibition of nuclear factor kappa‐B signal and stemness properties

  • Source: MedComm ; volume 5, issue 5 ; ISSN 2688-2663 2688-2663

Record details

Read More Add to Saved list
×
Academic Journal

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study

  • Source: European Journal of Haematology ; volume 113, issue 2, page 190-200 ; ISSN 0902-4441 1600-0609

Record details

Read More Add to Saved list
×
Academic Journal

A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies

  • Source: European Journal of Haematology ; ISSN 0902-4441 1600-0609

Record details

Read More Add to Saved list
×
Academic Journal

P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY DRUG (IMID) AND A PROTEASOME INHIBITOR (PI) OR HAD RECEIVED ≥3 PRIOR LINES OF THERAPY INCLUDING AN IMID AND A PI

  • Source: HemaSphere ; volume 7, issue S2, page 29-30 ; ISSN 2572-9241

Record details

Read More Add to Saved list
×
Academic Journal

P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY

  • Source: HemaSphere ; volume 7, issue S2, page 30-31 ; ISSN 2572-9241

Record details

Read More Add to Saved list
×
Academic Journal

P953: PHASE I STUDY OF TQB3602 CAPSULE, AN ORAL PROTEASOME INHIBITOR, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

  • Source: HemaSphere ; volume 6, page 843-844 ; ISSN 2572-9241

Record details

Read More Add to Saved list
×
Academic Journal

PB2019: EFFICACY AND SAFETY OF IXAZOMIB PLUS LENALIDOMIDE AND DEXAMETHASONE FOLLOWING INJECTABLE PROTEASOME INHIBITOR-BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

  • Source: HemaSphere ; volume 6, page 1890-1891 ; ISSN 2572-9241

Record details

Read More Add to Saved list
×
Academic Journal

A phase I/ II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)

  • Source: American Journal of Hematology ; volume 96, issue 12, page 1595-1603 ; ISSN 0361-8609 1096-8652

Record details

Read More Add to Saved list
×
  • 1-10 of  439 results for ""Proteasome Inhibitor""